Erythromycin NDC 13668-606

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-606Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0606Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
13668-606-01	13668060601	100 TABLET, COATED in 1 BOTTLE (13668-606-01)Marketed from Jul 6, 2020
13668-606-05	13668060605	500 TABLET, COATED in 1 BOTTLE (13668-606-05)Marketed from Jul 7, 2020
13668-606-30	13668060630	30 TABLET, COATED in 1 BOTTLE (13668-606-30)Marketed from Apr 12, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 250 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Torrent Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212015
Marketing start: Jul 6, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 13668-606_be7fded9-0e2a-4b0e-b668-7be090de7919SPL ID be7fded9-0e2a-4b0e-b668-7be090de7919SPL set ID 933049f6-61b9-4ed5-b6b7-60c5037e2115RxCUI 197650, 598006UNII 63937KV33DUPC 0313668607307, 0313668606300
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668060601 followed by a unit qualifier and the quantity

Package 13668-0606-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 5, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, USP and other antibacterial drugs, erythromycin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin tablet, USP are indicated in the treatment of infections caused by susceptible strains of the designated m…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212015

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212015
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 500 mg/1	Tablet, CoatedOral	Torrent Pharmaceuticals Limited	13668-607
Erythromycin	Erythromycin 500 mg/1	Tablet, CoatedOral	Golden State Medical Supply, Inc.	51407-856
Erythromycin	Erythromycin 250 mg/1	Tablet, CoatedOral	Golden State Medical Supply, Inc.	51407-855